Systematic DRPx Summit 2015
Date: | 21-Oct-15 to 22-Oct-15 |
Location: | Boston Park Plaza / Boston / United States |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
Systematic DRPx enables you to systematically repurpose failed, shelved and existing drugs for their true disease indication to dramatically improve clinical outcomes and maximize true commercial value. Sidestep drug development bottlenecks, dramatically improve compound and target identification, and extract additional value from pre-existing R&D investments.
Systematic DRPx Summit will address how drug repurposing can become a core component of your R&D by demonstrating when and how to implement a successful strategy. Learn to de-risk the transformation of previous failures into future clinical and commercial success from industry leaders including AstraZeneca and Biovista.
Leading experts from GSK, NIH and CureHunter will demonstrate how advanced high-throughput screening platforms and analytics have streamlined a systematic drug repurposing approach to rescue shelved compounds and optimize existing drugs.
This summit will provide drug developers with a platform to discuss strategies to optimize ROI on failed portfolio assets, and through case study-driven talks to accurately position your drug for the correct disease indication from the outset.
Systematic DRPx Summit will address how drug repurposing can become a core component of your R&D by demonstrating when and how to implement a successful strategy. Learn to de-risk the transformation of previous failures into future clinical and commercial success from industry leaders including AstraZeneca and Biovista.
Leading experts from GSK, NIH and CureHunter will demonstrate how advanced high-throughput screening platforms and analytics have streamlined a systematic drug repurposing approach to rescue shelved compounds and optimize existing drugs.
This summit will provide drug developers with a platform to discuss strategies to optimize ROI on failed portfolio assets, and through case study-driven talks to accurately position your drug for the correct disease indication from the outset.
Exhibitors
David Brown, Aris Persidis, Daniel Gil, Craig Wegner, Christine Colvis, Mark Hurle, Felix Sheinerman, Jordan Miller, Jake Liang, Stephen Wong, Usman Iqbal, Chris Gibson, Charles Niebylski, Judge Schonfeld, Eleftherios Mylonakis
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today